Namibia: Concern As BMS Starts Handover of HIV/Aids Treatment

Katima Mulilo — Almost three years ago, the privately funded Mapilelo ('Place of Survival') project began providing people in the impoverished northeastern Caprivi region with anti-AIDS drugs.

But with pharmaceutical company Bristol-Myers Squibb (BMS) announcing the end of its funding in September, concerns have been raised over the future of the project, which has about 1,700 people on antiretroviral (ARV) medication.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.